AfterPlan
AfterPlan is an FDA drug label for the active ingredient LEVONORGESTREL manufactured by SUN PHARMACEUTICAL INDUSTRIES, INC. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20181026.
- Generic name
- LEVONORGESTREL
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES, INC.
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 62756-723
- Application
- ANDA202635
- Label effective
- 20181026
Active ingredients
Indications & Usage
Use for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)
Dosage & Administration
Directions 1. take as soon as possible within 72 hours (3 days) after unprotected sex. The sooner you take it, the better it will work. 2. if you vomit within 2 hours after taking the medication, call a healthcare professional to find out if you should repeat the dose
Contraindications
Not available.
Warnings
Warnings Allergy alert Do not use if you have ever had an allergic reaction to levonorgestrel Sexually transmitted diseases (STDs) alert This product does not protect against HIV/AIDS or other STDs. Do not use 1. if you are already pregnant (because it will not work) 2. for regular birth control Ask a doctor or pharmacist before use if you are taking efavirenz (HIV medication) or rifampin (tuberculosis treatment) or medication for seizures (epilepsy). These medications may reduce the effectiveness of levonorgestrel. When using this product you may have 1. menstrual changes 2. tiredness 3. dizziness 4. nausea 5. headache 6. breast pain 7. lower stomach (abdominal) pain 8. vomiting Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
Adverse Reactions
Not available.